Science policy weekly roundup: July 13, 2018 ?>

Science policy weekly roundup: July 13, 2018

The NSF launches STEM education advisory panel

The National Science Foundation announced the formation of an 18-member STEM education advisory panel to promote U.S. innovation in science and technology education. The panel will assess the Committee on Science, Technology, Engineering and Mathematics Education, a group of federal organizations that aims to support and improve the U.S. STEM community. Read more here.  


Payments to FDA panelists by pharmaceutical companies highlight possible ethics breach

Reporters from Science magazine have found that physicians on the Food and Drug Administration panels to approve new drug therapies were paid by pharmaceutical companies that manufactured the drugs between 2008 and 2014. Current conflict-of-interest policies apply to disclosures made only before the panels convene. Because the payments were made after the drugs’ approvals, no red flags had been raised. These post-approval payments demonstrate a loophole that pharmaceutical companies have been exploiting. Read more here. 


National Academies report recommends increased data transparency for study participants

A National Academies of Sciences, Engineering and Medicine report published Tuesday recommends that scientists share research findings with participants of biomedical studies. While researchers are concerned that individuals could misinterpret scientific results, an increasing number of participants want to know their results. The National Institutes of Health’s All of Us initiative, which aims to profile the health of 1 million Americans, has announced that it will share data with participants. Read more here. 


Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.